← Leaderboards
Estella M Alonso
Lurie Children'S Hospital Of Chicago
$12,555,590
Attributed
$19,264,599
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,264,599 · 5
AHRQ$0 · 1
By mechanism
U01$16,381,230 · 2
R01$2,155,269 · 1
U34$728,100 · 1
M01$0 · 1
R03$0 · 1
Top collaborators
- Valerie L Durkalski4 shared
Most similar at Lurie Children'S Hospital Of Chicago
Same institution · by research overlap
- Valerie L Durkalski$19,943,358
- Alyssa Kriegermeier$327,372
Others in their field
Top investigators on “Liver Transplantation”
- John C Magee · University Of Michigan At Ann Arbor$32,824,292
- Robert M Merion · University Of Michigan At Ann Arbor$32,380,845
- Jeffrey S Glenn · Stanford University$29,122,918
- Peter G Stock · University Of California San Francisco$27,203,354
- William M Lee · University Of Texas Sw Med Ctr/Dallas$24,215,692
- Dorry Segev · Johns Hopkins University$23,097,210
Research focus
Liver TransplantationChildChildhoodLiverResponsePathogenesisMortalityPublic HealthFunctional DisorderEtiologyResearch StudyBiobankLiver DiseasesInflammatoryPatternSamplingAffectPreventBiliary AtresiaPatient Outcomes AssessmentsEfficacy TestingEnrollmentDisease ProgressionDouble-Blind Method
Grant awards (24)
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$2,180,043
U01 · FY2025 · DK · contact PI
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$3,678,947
U01 · FY2024 · DK · contact PI
Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers$360,000
U01 · FY2023 · DK · contact PI
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$3,894,611
U01 · FY2022 · DK · contact PI
Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers$389,273
U01 · FY2022 · DK · contact PI
Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH)$3,664,418
U01 · FY2021 · DK · contact PI
Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers$376,261
U01 · FY2021 · DK · contact PI
Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers$360,867
U01 · FY2020 · DK · contact PI
Macrophage Cell Subset Specific Biomarkers for Disease Prognosis in Biliary Atresia$167,700
U01 · FY2020 · DK · contact PI
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)$343,872
U34 · FY2019 · DK · contact PI
Childhood Liver Disease Research Network (ChiLDReN) Clinical Centers$287,214
U01 · FY2019 · DK · contact PI
Pediatric Acute Liver Failure (PALF) TReatment for ImmUne Mediated PathopHysiology (TRIUMPH)$384,228
U34 · FY2018 · DK · contact PI
Clinical Center: ChiLDReN (Childhood Liver Disease Research Network)$363,159
U01 · FY2018 · DK · contact PI
Clinical Center: ChiLDReN (Childhood Liver Disease Research Network)$319,612
U01 · FY2017 · DK · contact PI
Clinical Center: ChiLDReN (Childhood Liver Disease Research Network)$339,125
U01 · FY2016 · DK · contact PI
Functional Outcomes in Pediatric Liver Transplantation$372,003
R01 · FY2009 · HD · contact PI
Functional Outcomes in Pediatric Liver Transplantation$382,492
R01 · FY2008 · HD · contact PI
Functional Outcomes in Pediatric Liver Transplantation$442,639
R01 · FY2007 · HD · contact PI
Functional Outcomes in Pediatric Liver Transplantation$420,225
R01 · FY2006 · HD · contact PI
Functional Outcomes in Pediatric Liver Transplantation$537,910
R01 · FY2005 · HD
Quality of Life in Children After Liver Transplantation$0
R03 · FY2003 · HS
Quality of Life in Children After Liver Transplantation$0
R03 · FY2002 · HS
INTRAVENOUS CYTOGAM TO PREVENT EPSTEIN BARR VIRUS IN PEDIATRIC LIVER TRANSPLANT$0
M01 · FY2001 · RR
INTRAVENOUS CYTOGAM TO PREVENT EPSTEIN BARR VIRUS IN PEDIATRIC LIVER TRANSPLANT$0
M01 · FY2000 · RR